Stay updated on Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.

Latest updates to the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedLocations section added listing Arizona, California, New York, Ohio, Pennsylvania, and Texas sites. The page also shows a revision note indicating v3.3.3.SummaryDifference0.8%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2 with no visible changes to study content in the screenshots.SummaryDifference0.1%

- Check36 days agoChange DetectedDeletion of a government funding status notice; this change does not affect the study details, locations, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedChanges appear to be minor layout and UI updates that do not modify the Study Details, eligibility criteria, or other core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check79 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference4%

- Check86 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.